These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16617663)

  • 41. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
    Al-Kasim FA; Thornley I; Rolland M; Lau W; Tsang R; Freedman MH; Saunders EF; Calderwood S; Doyle JJ
    Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Bone marrow transplantation in adults in acute leukemia, aplastic anemia and paroxysmal nocturnal hemoglobinuria. Results of the Medical Clinic IIi of LMU (Ludwig-Maximilians University) Munich].
    Jehn U; Sauer H; Kolb HJ; Fink M; Ledderose G; Brehm G; Wilmanns W; Eckstein R; Heim M; Mempel W; von Lieven H; Bunde E; Rohloff R; Balk O; Hochhäuser E
    Klin Wochenschr; 1983 Apr; 61(7):321-8. PubMed ID: 6345918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
    Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
    Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution.
    Al-Qurashi F; Ayas M; Al Sharif F; Ibrahim E; Sahovic E; Al Mahr M; Chaudhri N; Al Mohareb F; Al Zahrani H; Al Jefri A; Al Omar H; Al Shanqeeti A; Seth P; Aslam M; El Solh H; Aljurf M
    Hematology; 2004 Apr; 9(2):123-9. PubMed ID: 15203867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model.
    Ploemacher RE; Johnson KW; Rombouts EJ; Etienne K; Westerhof GR; Baumgart J; White-Scharf ME; Down JD
    Biol Blood Marrow Transplant; 2004 Apr; 10(4):236-45. PubMed ID: 15077222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intra- and interlaboratory variability of paroxysmal nocturnal hemoglobinuria testing by flow cytometry following the 2012 Practical Guidelines for high-sensitivity paroxysmal nocturnal hemoglobinuria testing.
    Marinov I; Kohoutová M; Tkáčová V; Lysák D; Holubová M; Stehlíková O; Železníková T; Žontar D; Illingworth A
    Cytometry B Clin Cytom; 2013; 84(4):229-36. PubMed ID: 23325604
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paroxysmal nocturnal hemoglobinuria.
    Parker CJ
    Curr Opin Hematol; 2012 May; 19(3):141-8. PubMed ID: 22395662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
    Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
    Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute leukaemia in paroxysmal nocturnal haemoglobinuria. Case report and review of the literature.
    Cornélis F; Montfort L; Osselaer JC; Sonet A; Doyen C; Chatelain C; Chatelain B; Bosly A
    Hematol Cell Ther; 1996 Jul; 38(3):285-8. PubMed ID: 8974794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone marrow failure syndromes: paroxysmal nocturnal hemoglobinuria.
    Parker CJ
    Hematol Oncol Clin North Am; 2009 Apr; 23(2):333-46. PubMed ID: 19327587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing donor chimerism using flow cytometry in paroxysmal nocturnal haemoglobinuria after stem cell transplantation--a case report.
    Azma RZ; Hamidah NH; Leong CF; Ainoon O; Cheong SK
    Malays J Pathol; 2006 Dec; 28(2):107-12. PubMed ID: 18376800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Paroxysmal nocturnal hemoglobinuria: the price for a chance.
    Bessler M
    Schweiz Med Wochenschr; 1996 Nov; 126(45):1912-21. PubMed ID: 8946596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Last marrow standing: bone marrow transplantation for acquired bone marrow failure conditions.
    Gerds AT; Scott BL
    Curr Hematol Malig Rep; 2012 Dec; 7(4):292-9. PubMed ID: 23065408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stem cell transplantation for paroxysmal nocturnal hemoglobinuria.
    Brodsky RA
    Haematologica; 2010 Jun; 95(6):855-6. PubMed ID: 20513803
    [No Abstract]   [Full Text] [Related]  

  • 58. Hypomegakaryocytic thrombocytopenia and increased number of PNH-phenotype cells - an emerging subgroup of myelodysplastic syndrome showing frequent response to immunosuppression - RESPONSE to Rafferty & Leach.
    Nakao S; Ishiyama K
    Br J Haematol; 2018 Jul; 182(1):154-155. PubMed ID: 28589553
    [No Abstract]   [Full Text] [Related]  

  • 59. Paroxysmal nocturnal hemoglobinuria (PNH): an historical perspective.
    Benz EJ
    Hematology Am Soc Hematol Educ Program; 2008; ():92. PubMed ID: 19074064
    [No Abstract]   [Full Text] [Related]  

  • 60. Transfusion of PNH patients.
    Sirchia G; Zanella A
    Transfusion; 1990 Jun; 30(5):479. PubMed ID: 2360245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.